Study name	Intervention(s)	Control	Mean or median change score of final score in intervention(s)	Mean or median change score of final score in control	Difference in mean or median
Sanyal 2010	Thiazolidinediones	Antioxidants	‐0.4 ‐0.3	‐0.1	‐0.3 ‐0.2
Gomez 2009	Antioxidants	No intervention	‐0.72	‐0.55	‐0.17
Harrison 2003	Antioxidants	No intervention	‐0.67	‐0.3	‐0.37
Leuschner 2010	Bile acids	No intervention	0	‐0.08	0.08
Lindor 2004	Bile acids	No intervention	0	‐0.1	0.1
Neuschwander‐Tetri 2015	Bile acids	No intervention	‐0.2	0.1	‐0.3*
Dufour 2006	Bile acids plus antioxidants Bile acids	No intervention	0.44 0.32	0.56	‐0.10 ‐0.24
Armstrong 2016	Other anti‐diabetes medication	No intervention	‐0.2	‐0.2	0
Loomba 2015	Other cholesterol‐lowering agents	No intervention	1	1	0
Van Wagner 2011	Pentoxifylline	No intervention	‐0.2	0.4	‐0.6
Alam 2016	Renin‐angiotensin‐aldosterone system inhibitor	No intervention	‐0.65	0.3	‐0.95*
Chan 2015	Silymarin	No intervention	‐0.367	0.147	‐0.514
Shields 2009	Sulphonylureas	No intervention	1.56	1.9	‐0.34
Uygun 2004	Sulphonylureas	No intervention	0.92	1.12	‐0.2
Belfort 2006	Thiazolidinediones	No intervention	‐0.9	‐0.63	‐0.27
Ratziu 2008	Thiazolidinediones	No intervention	0.03	‐0.18	0.21
Sharma 2012	Pentoxifylline	Thiazolidinediones	0.91	0.9	0.01
Torres 2011	Thiazolidinediones plus renin‐angiotensin‐aldosterone system inhibitor Thiazolidinediones plus sulphonylureas	Thiazolidinediones	‐0.32 ‐0.59	‐0.7	0.38 0.11
Footnotes Lower indicates better * = statistically significant difference